Edwards Lifesciences Issuance Repayment of Debt Securities Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 110.05  1.53  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Issuance Repayment of Debt Securities of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from issuance (repayment) of debt securities.
Issuance Repayment of Debt Securities   10 Years Trend  
Increasing
Slightly volatile
 Issuance Repayment of Debt Securities  
      Timeline 

Edwards Lifesciences Issuance Repayment of Debt Securities Over Time

2015-12-31  1,900,000 
2016-12-31  222,100,000 
2017-12-31  117,894,737 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  60,816,228
Coefficient Of Variation  235.6
Mean Deviation  107,352,266
Median  39,500,000
Standard Deviation  143,280,747
Range  495,800,000
R Value  0.49
R Squared  0.24
Significance  0.11
Slope  19,292,105

Currently Trending

BSX   
 NYQ 
Purchased over 200 shares of
3 hours ago ago
Traded for 29.4
HCA   
 NYQ 
Purchased over 70 shares of
3 hours ago ago
Traded for 0.0
INCY   
 NMS 
Purchased over 40 shares of
3 hours ago ago
Traded for 0.0